Literature DB >> 23395519

Successful treatment of severe delayed pressure angio-oedema with omalizumab.

M Rodríguez-Rodríguez1, D Antolin-Amerigo2, J Barbarroja-Escudero3, M J Sánchez-González4, M Alvarez-Mon5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23395519     DOI： 10.1016/j.aller.2012.11.001

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN： 0301-0546            Impact factor:   1.667


× No keyword cloud information.
  2 in total

Review 1.  Review of Physical Urticarias and Testing Methods.

Authors:  Mario Sánchez-Borges; Luis González-Aveledo; Fernan Caballero-Fonseca; Arnaldo Capriles-Hulett
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 2.  Off-Label Uses of Omalizumab.

Authors:  David El-Qutob
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.